Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 3
1982 2
1983 3
1984 1
1985 1
1988 4
1992 3
1994 3
1995 2
1996 2
1997 1
1998 4
1999 5
2000 2
2001 3
2002 1
2003 1
2004 5
2005 2
2006 3
2007 7
2008 4
2009 6
2010 3
2011 2
2012 2
2013 2
2014 6
2015 1
2016 2
2017 1
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Experimental teratoma: at the crossroad of fetal- and onco-development.
Hultman I, Björk L, Blomberg E, Sandstedt B, Ahrlund-Richter L. Hultman I, et al. Among authors: ahrlund richter l. Semin Cancer Biol. 2014 Dec;29:75-9. doi: 10.1016/j.semcancer.2014.08.005. Epub 2014 Aug 19. Semin Cancer Biol. 2014. PMID: 25153353 Review.
Oncofetal signaling as a target for cancer therapy.
Ahrlund-Richter L, Hendrix MJ. Ahrlund-Richter L, et al. Semin Cancer Biol. 2014 Dec;29:1-2. doi: 10.1016/j.semcancer.2014.08.001. Epub 2014 Aug 8. Semin Cancer Biol. 2014. PMID: 25111377 No abstract available.
New ISSCR guidelines underscore major principles for responsible translational stem cell research.
Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. Hyun I, et al. Among authors: ahrlund richter l. Cell Stem Cell. 2008 Dec 4;3(6):607-9. doi: 10.1016/j.stem.2008.11.009. Cell Stem Cell. 2008. PMID: 19041777 Free article. Review.
Nodal expression and detection in cancer: experience and challenges.
Strizzi L, Hardy KM, Kirschmann DA, Ahrlund-Richter L, Hendrix MJ. Strizzi L, et al. Among authors: ahrlund richter l. Cancer Res. 2012 Apr 15;72(8):1915-20. doi: 10.1158/0008-5472.CAN-11-3419. Cancer Res. 2012. PMID: 22508696 Free PMC article. Review.
One explanation for F1 antiparent responses.
Dalianis T, Ahrlund-Richter L. Dalianis T, et al. Among authors: ahrlund richter l. Immunol Today. 1992 Jul;13(7):248-50. doi: 10.1016/0167-5699(92)90004-Q. Immunol Today. 1992. PMID: 1388650
[Ribozyme-based gene therapy of HIV].
Britton S, Larsson S, Ahrlund-Richter L. Britton S, et al. Among authors: ahrlund richter l. Lakartidningen. 1994 Sep 28;91(39):3491-4. Lakartidningen. 1994. PMID: 7990586 Review. Swedish. No abstract available.
Characterization of stem-like cells in mucoepidermoid tracheal paediatric tumor.
Lim ML, Ooi BN, Jungebluth P, Sjöqvist S, Hultman I, Lemon G, Gustafsson Y, Asmundsson J, Baiguera S, Douagi I, Gilevich I, Popova A, Haag JC, Rodríguez AB, Lim J, Liedén A, Nordenskjöld M, Alici E, Baker D, Unger C, Luedde T, Vassiliev I, Inzunza J, Ahrlund-Richter L, Macchiarini P. Lim ML, et al. Among authors: ahrlund richter l. PLoS One. 2014 Sep 17;9(9):e107712. doi: 10.1371/journal.pone.0107712. eCollection 2014. PLoS One. 2014. PMID: 25229469 Free PMC article.
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma.
Hultman I, Haeggblom L, Rognmo I, Jansson Edqvist J, Blomberg E, Ali R, Phillips L, Sandstedt B, Kogner P, Shirazi Fard S, Ährlund-Richter L. Hultman I, et al. Among authors: ahrlund richter l. PLoS One. 2018 Jan 17;13(1):e0190970. doi: 10.1371/journal.pone.0190970. eCollection 2018. PLoS One. 2018. PMID: 29342186 Free PMC article.
Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines.
Ödborn Jönsson L, Sahi M, Lopez-Lorenzo X, Keller FL, Kostopoulou ON, Herold N, Ährlund-Richter L, Shirazi Fard S. Ödborn Jönsson L, et al. Among authors: ahrlund richter l. Int J Mol Sci. 2021 Apr 1;22(7):3664. doi: 10.3390/ijms22073664. Int J Mol Sci. 2021. PMID: 33915913 Free PMC article.
88 results